EPHB4 p.Pro841Leu
c.2522C>T · rs763645511 · VCV2521643
Computational evidence
| Protein change | ||
| AlphaMissense | 0.5937 | likely pathogenic |
|---|---|---|
| REVEL | 0.62 | indeterminate |
| SaProt | LLR -11.71 | damaging |
| ⇒ AlphaMissense and SaProt both call this damaging; REVEL is indeterminate. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 2.5, phastCons 1 |
| Regional constraint | o/e 0.87 | unconstrained · MANE · 3,002 bp · p 0.042 · regional, not allelic |
| Overall | ||
| CADD | 33.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.00339% | 29,490 |
| Admixed Americangrpmax | 0.00223% | 44,892 |
| European (non-Finnish) | 0.00192% | 51,970 |
| South Asian | 0.00127% | 78,762 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- EPHB4
- Protein
- p.Pro841Leu
- Coding
- c.2522C>T
- MANE Select
- NM_004444
- dbSNP
- rs763645511
- Type
- single nucleotide variant
- Location
- chr7:100805657 (GRCh38)
- Gene constraint
- LOEUF 0.645 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 82.46 · 23 PDB
- Residue 841
- an α-helix; a UniProt-annotated variant site (in cmavm2); the protein kinase domain
Similar variants
- EPHB4 p.Pro841= Likely benign ★★ same residue
- EPHB4 p.Arg365Ter Pathogenic/Likely pathogenic ★★ same condition
- EPHB4 p.Arg739Gln Pathogenic ★★ same condition
- EPHB4 p.Gln580Ter Pathogenic/Likely pathogenic ★★ same condition
- EPHB4 p.Ser280Ter Pathogenic/Likely pathogenic ★★ same condition
- EPHB4 p.Lys859Arg Uncertain significance ★★ ⚠ same condition
- EPHB4 p.Met728Val Uncertain significance ★★ ⚠ same condition
- EPHB4 p.Ser299Leu Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ephb4-p-pro841leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown